Tujuan Untuk mengetahui kejadian VTE pada pasien Indonesia yang menjalani bedah ortopedi mayor dan tidak menerima tromboprofi laksis. 
In Asian patients undergoing surgery, the incidence of venous thromboembolism (VTE) is believed to be low relative to Western patients, and the routine use of thromboprophylaxis is controversial. However, in a recent review of published studies in Asian patients undergoing surgery and not receiving thromboprophylaxis 1 , the adjusted incidence of total (asymptomatic and symptomatic) deep vein thrombosis (DVT) was 13% in general surgery, 16% after total hip replacement, 50% after total knee replacement, and 18% after hip fracture surgery. The adjusted incidence of symptomatic pulmonary embolism (PE) was 1% in general surgery and 1.4% after total hip replacement. In autopsy studies, the incidence of fatal PE increasing consistently from 0.2% to 6.0% over a period of 30 years in Japan and Hongkong. 1 A study in Malaysian patients who had orthopedic surgery with no prophylaxis against DVT 2 showed that the venographic DVT was 62.5%, it was highest after total knee replacement (76.5%), less after total hip replacement (64.3%), and lowest in the fracture group (50%). One patient developed symptomatic PE.
The epidemiological study of VTE in Asian patients undergoing major orthopedic surgery without thromboprophylaxis (the SMART Study) 3 showed that the rate of the composite of symptomatic VTE or sudden death at hospital discharge was 1.2% after adjudication by an independent committee. The rates of symptomatic VTE, DVT and PE were 1.0%, 0.9% and 0.2%, respectively. The rates of the composite outcome were 1.4% in patients undergoing total knee replacement surgery and 1.0% in patients operated on for hip fracture or total hip replacement. Sudden death was reported in hip fracture surgery patients (0.4%) only. At 1 month's follow-up, the incidence of adjudicated symptomatic VTE or sudden death was 1.5%.
In addition, results of the SMART venography study (a part of the SMART program, conducted in different patients and centers) 4 showed that in Asian patients undergoing hip or knee surgery and not receiving pharmacological thromboprophylaxis, the rate of the composite of adjudicated asymptomatic or symptomatic VTE or sudden death up to hospital discharge was 36.5%. The rate of symptomatic VTE (all were symptomatic DVT) was 0.9%. The rate of the composite outcome at the 1-month follow-up was 1.5%.
The above studies suggest that in Asian patients, the incidence of symptomatic VTE after major orthopedic surgery is not low, but comparable to the rates observed in Western countries 5, 6 . The aim of the present study was to estimate the incidence of VTE defi ned as symptomatic or asymptomatic DVT or PE or sudden death in Indonesian patients undergoing total hip or knee replacement or surgery for hip fracture or acute spinal cord injury or major trauma or pelvis fracture and not receiving thromboprophylaxis. VTE was detected by systematic bilateral venography performed between days 5 and 8 after surgery. The secondary objective was to describe the clinical features of the VTE.
METHODS
This was an open clinical study of consecutive Indonesian patients undergoing major orthopedic surgeries. It was conducted in 3 centers in Jakarta, Cipto Mangunkusumo General National Hospital, Saint Carolus Hospital, and Fatmawati General Hospital, started in March 2003 and ended in March 2004 .
Patients
Indonesian patients aged at least 40 years, hospitalized for total hip or knee replacement or hip fracture or acute spinal cord injury or major trauma or pelvis fracture, were recruited. Patients having received any thromboprophylaxis treatment within the week preceding inclusion, and those with contraindication to venography, were excluded. Pregnant women and patients refusing informed consent to participate were also excluded.
Study procedures
The following patient and surgery characteristics were recorded as potential risk factors for symptomatic VTE or sudden death (primary outcome) : age, gender, weight and height, smoking habit, history of cancer or currently active cancer, personal or familial history of VTE, known thrombophilia, peptic ulcer, chronic heart failure, varicose veins, myocardial infraction, arterial hypertension, hormone therapy (estrogen, hormone replacement therapy, or anti-androgen), blood glucose level, D-dimer level, time between injury and surgery, duration of surgery, type of anesthesia (general or regional), surgery sites, duration of immobilization, complications after surgery, concomitant treatments after surgery.
Patients underwent a bilateral ascending contrast venography of the lower extremities using Rabinov & Paulin technique to detect asymptomatic DVT. If a DVT is clinically suspected before Day 5, the diagnosis should be confi rmed by venography within 48 hours. Clinical suspicion of PE should be objectively confi rmed by highprobability lung scanning or pulmonary angiography, or at autopsy or, in patients who died suddenly without autopsy and whose clinical history was that of a death by PE, as adjudicated by the physicians.
After hospital discharge, patients were contacted, by mail, telephone or visit in person, 1 month (between day 30 and day 37) after surgery and asked to report any symptoms and signs of VTE, bleeding, rehospitalization, or survival status (dead/alive). In patients presenting with VTE (symptomatic DVT/PE or objectively by venography), the decision of treatment was left to the investigator's discretion.
The following bleeding complications up to hospital discharge were recorded : fatal bleeding, bleeding leading to re-operation, bleeding requiring transfusion of at least 2 units of packed red blood cells or whole blood, bleeding leading to a hemoglobin decrease > 20 g/L compared with baseline value, bleeding in a critical organ (retroperitoneal, intraocular or intracranial).
This study was conducted according to the standards of good clinical practice (the ICH E6 Guideline for Good Clinical Practice), in agreement with the Declaration of Helsinki and with local regulations. The protocol was approved by the Ethics Committee of the Medical Faculty, University of Indonesia, Jakarta, and written informed consent was obtained from each subject before inclusion into the study.
Study outcomes
The primary study outcome was the incidence of documented VTE (defi ned as asymptomatic or symptomatic DVT or PE) and sudden death at hospital discharge and at 1-month follow-up.
The secondary study outcome was the description of the clinical features of the VTE.
Data Analysis
The primary analysis was the incidence of documented VTE at hospital discharge and at one-month followup (day 30-day 37) in patients undergoing orthopedic surgery and not receiving pharmacological thromboprophylaxis. The data were analyzed according to descriptive statistics : number of cases, mean, median, standard deviation and range for quantitative data, and number of cases and percentages for qualitative data. The secondary analysis was the description of patients clinical features related to VTE.
RESULTS

Patient characteristics
Seventeen eligible patients were recruited. Female patients were three times more prevalent than males. The median age of the patients was 69 years (range 42-83 years). Among risk factors for VTE, only 1 patient (5.9%) had familial history of VTE, and no one had personal history of VTE or known thrombophilia. Cancer and varicose veins were not found in any of the 17 patients, while gastrointestinal disturbances were found in almost half of the patients (47.1%), and 3 patients (17.6%) had myocardial infarction. Stroke, chronic heart failure and hypertension were also not found in these patients, but diabetes and smoking were found in 5 patients (29.4%) and 1 patient (5.9%), respectively. Abnormal hematology was noted in 2 patients (11.8%) with anemia, 6 patients (35.3%) with leucocytosis, and 5 patients (29.4%) with high neutrophil count. Bleeding time >3 minutes was found in 1 patient (5.9%) and D-dimer level >400 mg/ mL in 9 patients (52.9%) ( Table 1) .
Surgical characteristics
Almost all patients (94.1%) underwent surgery for hip fracture ( Table 2 ). The median interval from injury to surgery was 23 days (range 2-197 days) and the median duration of surgery was 90 minutes (range 60-255 minutes). Surgery was conducted mainly under regional (spinal) anesthesia (94.1% of patients). The type of surgery was mainly hemiarthroplasty (in 64.7% of patients), followed by plate screw (in 23.5% of patients). The median duration of immobilization was 3 days (range 1-44 days).
Concomitant treatments after surgery
Postoperatively up to hospital discharge, no patient applied graduated compression device, while physiotherapy was provided to 15 patients (88.2%). Three patients with symptomatic VTE(see Table 3 ) were treated initially with a low molecular weight heparin, followed by warfarin (an oral anticoagulant) ( Table 2 ). Only 1 patient was given antiplatelet (aspirin). Fourteen patients (82.4%) received nonsteroid anti-infl ammatory drugs, and antibiotics were also given to 14 patients (82.4%) ( Table 2) .
VTE up to hospital discharge
From a total of 17 eligible patients, bilateral venography was performed in 13 patients (76.5%), all of them underwent surgery for hip fracture. Four patients refused and withdrew their consent. In 11 patients, venography was performed between days 5 and 8 after surgery (as planned), whereas in 2 patients it was performed after day 8 (1 on day 9 and 1 on day 10), with day 7 as the median (Table 3 ).
The rate of venographic VTE (asymptomatic or symptomatic DVT or PE) and sudden death (the primary outcome) up to hospital discharge was 69.2% (9 patients among 13 patients who underwent venography) ( Table 3) . Proximal DVT was present in 3 patients (23.1%), 2 patients with asymptomatic and 1 patient with symptomatic DVT. The rate of symptomatic VTE, all corresponding to clinical signs of DVT and no clinical sign of PE, was 23.1% (3 out of 13 patients). Among 6 patients with asymptomatic DVT, distal DVT occurred most frequently (in 5 patients). Sudden death did not occur and also there was no bleeding complication until hospital discharge in the present study. 
VTE up to 1-month follow-up
The same 13 patients who discharged from hospital without withdrawal of consent were followed up for a median of 31 days (range 28-36 days) after surgery. All were contacted by visit in person. From hospital discharge until the end of follow-up, no additional symptomatic VTE occurred, and also no sudden death, bleeding complication, nor re-hospitalization was found in the present study.
Clinical features of the VTE
In the present study, the symptomatic VTE occurred in 3 
DISCUSSION
Venous thromboembolism (VTE) is a serious complication most commonly occur after surgery, major trauma or immobilization 5 . VTE includes deep venous thrombosis (DVT) and pulmonary embolism (PE), approximately one third of patients with VTE have a PE, whereas two thirds have DVT alone 7 . In Western countries, the absolute risk of DVT in hospitalized patients not receiving thromboprophylaxis ranges from 10 to 80%, the lowest in medical patients (10-20%), and the highest in spinal cord injury (60-80%), major trauma (40-80%) and orthopedic surgery (40-60%) 5 . Therefore, thromboprophylaxis is warranted, because DVT and PE are mostly asymptomatic and it is diffi cult to predict which patients will develop symptomatic DVT or PE which cause serious morbidity and mortality, while thromboprophylaxis is highly effi cacious at preventing asymptomatic and symptomatic DVT and fatal PE 5, 6 . The present study was to verify the results of the previous Asian studies about the incidence of VTE in patients undergoing orthopedic surgery without thromboprophylaxis in Indonesian patients. The planned sample size for this study was 62 patients examined for DVT using venography, but only 17 eligible patients were enrolled and only 13 patients (76.5%) were willing to undergo venography. Bilateral contrast venography using Rabinov & Paulin technique was used to detect asymptomatic DVT in this study. Although invasive, venography is considered the gold standard diagnostic technique for this purpose, because it is both sensitive and specifi c. 8 We found in the present study, the rate of venographic VTE (asymptomatic or symptomatic DVT or PE) and sudden death (the primary outcome) was 69.2% and the rate of proximal DVT was 23.1% at hospital discharge, and these rates were from patients undergoing hip fracture surgery (HFS). Compared to other studies conducted in Asia, these rates were too high, considering our patients had a low-risk profi le for VTE (see Table 1 ). Also, almost all of the patients (94.1%) received regional anesthesia, which reportedly associated with less DVT after HFS 5 . From the exhaustive literature search for published studies on VTE in Asia 1 , the incidence of total venographic DVT in 141 HFS patients ranged from 6.9 to 50.0%, and that of venographic proximal DVT was 2.8 to 3.4%. In the Malaysian study 2 , the incidence of venographic DVT in 88 patients with orthopedic surgery was 62.5% and that in 40 patients with proximal femoral fracture was 50%. In the SMART (Surgical Multinational Asian Registry in Thrombosis) venography study 4 , there was no HFS patients, while the rate of venographic VTE (asymptomatic or symptomatic DVT) in 326 patients with hip and knee replacement surgery was 36.5% and that of proximal DVT was 9.8% at hospital discharge. In the AIDA (Assessment of the Incidence of Deepvein thrombosis in Asia) 9 , the incidence of venographic DVT in 69 HFS patients was 42.0%, and that of proximal DVT was 7.2%. By-country analysis in AIDA study showed that the highest DVT rate occurred in Indonesia (78.6%), but it was not mentioned from how many patients. Considering the Malay ethnic consisted of only 12 patients in AIDA study, we assumed that the number of Indonesian patients in that study was small, as it was in the present study. In Western patients, the rate of venographic DVT after HFS ranged form 46 to 60%, and that of proximal DVT was 23 to 30% 5, 6 . The proximal DVT is more important than the distal DVT because proximal DVT is considered to have a higher risk of embolizing than distal DVT. 10 The high risk of VTE in the present HFS patients may be due to the advanced age (median 69 years) and the predominant women (76.5%) in this study (see Table  1 ). The same was true in Western studies 5 and in AIDA study 9 . Delayed surgery also increased the risk of VTE in HFS patients. The incidence of preoperative DVT as shown by venography was 62% for all DVT and 14% for proximal DVT when the delay was 48 hours or more. 5, 6 To confi rm clinical suspicion of PE, a high-probability lung scan has the positive predictive value of 93%, while pulmonary angiography is considered the gold standard diagnostic technique for PE 8 . In the present study, the rate of symptomatic VTE was 25%, all corresponding to clinical signs of DVT and no clinical sign of PE. In the review of all previously published studies on VTE in Asia 1 , the rate of symptomatic DVT in 53 HFS patients was 28.3% and no symptomatic PE was found among all of the HFS patients. In the Malaysian study 2 , the rate of symptomatic DVT in 55 patients with venographic DVT was 34.5%, and 1 patient developed clinical features of PE. In the SMART study 3 , the rate of symptomatic DVT in 1068 HFS patients was 0.5% and that of symptomatic PE was 0.3% up to hospital discharge. In SMART venography study 4 , there was no HFS patients, while the rate of symptomatic DVT in 326 patients with hip and knee replacement surgery was 0.9%, and no symptomatic PE was found up to hospital discharge. In AIDA study 9 , the rate of symptomatic DVT in 374 patients with a venogram was 12.6%, while a perfusion-lung-scan confi rmed PE in 2 patients (0.5%). In Western patients, the rate of total symptomatic PE after HFS ranged from 3 to 11%, and the fatal PE was in the range of 2.5 to 7.5% within 3 months after HFS, a range higher than that seen after hip or knee arthroplasty. 5, 6 The 90-day risk of overall death was 13% 6 . Western patients after HFS are indeed at very high risk of VTE. Symptomatic VTE and fatal PE after HFS in these patients can be prevented with thromboprophylaxis. 5, 6 In the present study the rate of asymptomatic DVT was twice the rate of symptomatic VTE. This silent nature of VTE found in this study was consistent with the other Asian studies (the review of previous Asian studies, SMART study and AIDA study) 1,4,9 as well as with Western studies. 5 In the present study, there was no additional symptomatic VTE or death between hospital discharge and 1-month follow-up. The same was true in AIDA study 9 until 3-month follow-up, while in SMART study 3 , the additional number of cases was small, from 1.2% of patients at hospital discharge to 1.5% of patients at 1-month follow-up. In SMART venography study 4 , the additional number of cases was also small, from 3 patients at hospital discharge to 5 patients at 1-month follow-up. In Western studies, there were higher additional symptomatic VTE cases after hospital discharge, ranged between 2.7% and 4.3%. 5 Discrepancy between the Asian studies with the Western studies in this regard was primarily due to a lack of awareness of clinical symptoms of DVT, especially because non-specifi c symptoms in the legs are common after major hip or knee surgery.
In conclusion, the very high incidence of asymptomatic and symptomatic VTE after major orthopedic surgery without thromboprophylaxis in Indonesian patients found in the present study was higher than the results of the large Asian studies (SMART and AIDA), and still higher than the results of the Western studies. This may due to chance because of the small sample size of the study. Nevertheless, these results suggest that the incidence of VTE in Indonesian patients undergoing major orthopedic surgery is not low, and a larger study in Indonesian patients is required to establish the true incidence, and more importantly, that the use of thromboprophylaxis in these patients is warranted.
